Review
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 16, 2022; 10(29): 10413-10427
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10413
Table 2 Comparison of some improved criteria with Milan and expanded Malatya criteria on the basis of overall survival
Within criteriaOverall survival, %
1-yr
3-yr
5-yr
10-yr
Milan88.886.281.972.5
UCSF89837567
Up to Seven90867869
BCLC89837668
ETC88787061
Hangzhou88797061
Malatya90.185.279.772.8